SCHEMBL10683077

SCHEMBL10683077

CN(C)C(=O)C1CN(Cc2ccccc2)CCN1CCCC(c1ccc(F)cc1)c1ccc(F)cc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR2A P28223 4/20 0.50
ADRA1A P35348 4/20 0.50
HRH1 P35367 4/20 0.50
DRD3 P35462 4/20 0.50
OPRK1 P41145 4/20 0.50
SLC6A3 Q01959 4/20 0.50
OPRD1 P41143 3/20 0.50
CACNA1F O60840 3/20 0.50
DRD4 P21917 3/20 0.50
DRD5 P21918 3/20 0.50
HRH2 P25021 3/20 0.50
ADRA1D P25100 3/20 0.50
HTR7 P34969 3/20 0.50
ADRA1B P35368 3/20 0.50
OPRM1 P35372 3/20 0.50
HTR6 P50406 3/20 0.50
CACNA1D Q01668 3/20 0.50
CACNA1S Q13698 3/20 0.50
CACNA1C Q13936 3/20 0.50
HTR2C P28335 2/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10680546 0.87 SLC29A1 (0.54) HTR2AADRA1AHRH1DRD3OPRK1
SCHEMBL10677558 0.85 HTR2A (0.48) HTR2AADRA1AHRH1DRD3OPRK1
SCHEMBL10681966 0.80 SIGMAR1 (0.53) HTR2AADRA1AHRH1DRD3OPRK1
SCHEMBL10681399 0.78 CYP3A4 (0.46) HTR2AADRA1AHRH1DRD3OPRK1
SCHEMBL10679935 0.77 TACR1 (0.47) HTR2AADRA1AHRH1DRD3OPRK1
SCHEMBL8282943 0.72 CCR5 (0.58) CCR5KCNH2
SCHEMBL5024012 0.72 KCNH2 (0.72) KCNH2KDM4EHTT
SCHEMBL10555167 0.71 SLC6A3 (0.61) HTR2AADRA1AHRH1DRD3OPRK1
Fumaric Acid SCHEMBL10555818 0.71 HTR2A (0.61) HTR2AADRA1AHRH1DRD3OPRK1
Fumaric Acid SCHEMBL10555805 0.71 HTR2A (0.61) HTR2AADRA1AHRH1DRD3OPRK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4766125-A N-aryl-piperazinealkanamides useful for protecting hearts from myocardial injury caused by ischaemia, anoxia or hypoxia JANSSEN PHARMACEUTICA N.V. (BE) 1988-08-23 US disclosed
EP-0068544-B1 NOVEL N-ARYL-PIPERAZINEALKANAMIDES JANSSEN PHARMACEUTICA N.V. (BE) 1987-06-03 EP disclosed